Browse Wiki & Semantic Web

Jump to: navigation, search
Http://dbpedia.org/resource/Lineagen
  This page has no properties.
hide properties that link here 
  No properties link to this page.
 
http://dbpedia.org/resource/Lineagen
http://dbpedia.org/ontology/abstract Lineagen, Inc. is a privately held personaLineagen, Inc. is a privately held personal genomics and biotechnology company based in Salt Lake City, UT. The company was incorporated in 2006 and collaborated with two leading autism research institutions: the University of Utah and The Children's Hospital of Philadelphia (CHOP), to identify novel genetic variants likely causal of autism spectrum disorder. Lineagen was granted an exclusive commercial license to these novel genetic variants. Notably, the markers from CHOP, published in Nature and PLoS Genetics, were named by TIME magazine as one of the top ten medical breakthroughs of 2009. Since 2010, Lineagen provides genetic laboratory services to healthcare providers, which include fluorescence in situ hybridization (FISH), karyotyping and chromosomal microarray testing for children with childhood development disorders. In 2012, Lineagen and Affymetrix, Inc. announced that the companies have signed an agreement where Lineagen receives exclusive rights to develop a proprietary chromosomal microarray assay based on Affymetrix' GeneChip technology platform. Affymetrix' GeneChip technology platform.
http://dbpedia.org/ontology/foundingYear 2006
http://dbpedia.org/ontology/industry http://dbpedia.org/resource/Biotechnology +
http://dbpedia.org/ontology/product http://dbpedia.org/resource/Human_genome +
http://dbpedia.org/ontology/service http://dbpedia.org/resource/Medical_research + , http://dbpedia.org/resource/Genetic_testing +
http://dbpedia.org/ontology/type http://dbpedia.org/resource/Privately_held_company +
http://dbpedia.org/ontology/wikiPageID 53206042
http://dbpedia.org/ontology/wikiPageLength 5595
http://dbpedia.org/ontology/wikiPageRevisionID 1106988373
http://dbpedia.org/ontology/wikiPageWikiLink http://dbpedia.org/resource/Medical_research + , http://dbpedia.org/resource/Personal_genomics + , http://dbpedia.org/resource/Category:Companies_based_in_Salt_Lake_City + , http://dbpedia.org/resource/Time_%28magazine%29 + , http://dbpedia.org/resource/Human_genome + , http://dbpedia.org/resource/United_States + , http://dbpedia.org/resource/Affymetrix + , http://dbpedia.org/resource/Genetic_testing + , http://dbpedia.org/resource/DNA_microarray + , http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States + , http://dbpedia.org/resource/Comparative_genomic_hybridization + , http://dbpedia.org/resource/Salt_Lake_City%2C_Utah + , http://dbpedia.org/resource/Biotechnology + , http://dbpedia.org/resource/Children%27s_Hospital_of_Philadelphia + , http://dbpedia.org/resource/Privately_held_company + , http://dbpedia.org/resource/Nature_%28journal%29 + , http://dbpedia.org/resource/Karyotype + , http://dbpedia.org/resource/Fluorescence_in_situ_hybridization + , http://dbpedia.org/resource/University_of_Utah + , http://dbpedia.org/resource/PLOS_Genetics +
http://dbpedia.org/property/foundation March 2006
http://dbpedia.org/property/founders Michael S. Paul, Ph.D., Andy Peiffer, M.D., Ph.D.
http://dbpedia.org/property/industry http://dbpedia.org/resource/Biotechnology +
http://dbpedia.org/property/locationCity http://dbpedia.org/resource/Salt_Lake_City%2C_Utah +
http://dbpedia.org/property/locationCountry http://dbpedia.org/resource/United_States +
http://dbpedia.org/property/logoAlt Lineagen logo
http://dbpedia.org/property/name Lineagen, Inc.
http://dbpedia.org/property/products personal genome testing
http://dbpedia.org/property/services http://dbpedia.org/resource/Medical_research + , http://dbpedia.org/resource/Genetic_testing +
http://dbpedia.org/property/type http://dbpedia.org/resource/Privately_held_company +
http://dbpedia.org/property/wikiPageUsesTemplate http://dbpedia.org/resource/Template:Business-stub + , http://dbpedia.org/resource/Template:Infobox_company + , http://dbpedia.org/resource/Template:Utah-stub +
http://purl.org/dc/terms/subject http://dbpedia.org/resource/Category:Companies_based_in_Salt_Lake_City + , http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
http://www.w3.org/ns/prov#wasDerivedFrom http://en.wikipedia.org/wiki/Lineagen?oldid=1106988373&ns=0 +
http://xmlns.com/foaf/0.1/isPrimaryTopicOf http://en.wikipedia.org/wiki/Lineagen +
http://xmlns.com/foaf/0.1/name Lineagen, Inc.
owl:sameAs http://www.wikidata.org/entity/Q28873557 + , http://dbpedia.org/resource/Lineagen + , http://yago-knowledge.org/resource/Lineagen + , https://global.dbpedia.org/id/2fsPT +
rdf:type http://dbpedia.org/ontology/Company + , http://www.wikidata.org/entity/Q4830453 + , http://www.wikidata.org/entity/Q43229 + , http://schema.org/Organization + , http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson + , http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent + , http://dbpedia.org/ontology/Agent + , http://dbpedia.org/ontology/Organisation + , http://www.wikidata.org/entity/Q24229398 +
rdfs:comment Lineagen, Inc. is a privately held personaLineagen, Inc. is a privately held personal genomics and biotechnology company based in Salt Lake City, UT. The company was incorporated in 2006 and collaborated with two leading autism research institutions: the University of Utah and The Children's Hospital of Philadelphia (CHOP), to identify novel genetic variants likely causal of autism spectrum disorder. Lineagen was granted an exclusive commercial license to these novel genetic variants. Notably, the markers from CHOP, published in Nature and PLoS Genetics, were named by TIME magazine as one of the top ten medical breakthroughs of 2009.the top ten medical breakthroughs of 2009.
rdfs:label Lineagen
hide properties that link here 
http://dbpedia.org/resource/Tute_Genomics + http://dbpedia.org/ontology/wikiPageWikiLink
http://en.wikipedia.org/wiki/Lineagen + http://xmlns.com/foaf/0.1/primaryTopic
 

 

Enter the name of the page to start semantic browsing from.